Michael Levy to Drug-Eluting Stents
This is a "connection" page, showing publications Michael Levy has written about Drug-Eluting Stents.
Connection Strength
2.184
-
Ganatra S, Sharma A, Levy MS. Re-Evaluating the Safety of Drug-Eluting?Stents in Cancer Patients. JACC Cardiovasc Interv. 2017 11 27; 10(22):2334-2337.
Score: 0.561
-
Bang VV, Levy MS. Duration of dual anti-platelet therapy following drug eluting stents: Less Is More? Catheter Cardiovasc Interv. 2016 Mar; 87(4):733-4.
Score: 0.497
-
Majithia A, Levy MS. Drug eluting stents in primary PCI: ready for prime-time? Catheter Cardiovasc Interv. 2014 Nov 15; 84(6):963-4.
Score: 0.455
-
Parikh PP, Levy MS. Drug-eluting stents and diabetes: a generation gap? Catheter Cardiovasc Interv. 2013 Jun 01; 81(7):1115-6.
Score: 0.411
-
Ganatra S, Sharma A, Levy MS. A Differing Opinion on Primary Percutaneous Coronary Intervention in Patients Who Have Had Cancer: Stent Choice in Onco-cardiology Revisited. Mayo Clin Proc. 2017 08; 92(8):1315-1316.
Score: 0.137
-
Sharma AK, Levy MS. Implantation of everolimus-eluting bioresorbable scaffolds in a diabetic all-comers population--the future is now? Catheter Cardiovasc Interv. 2015 Nov 15; 86(6):982-3.
Score: 0.122